Optimas Capital’s Thermo Fisher Scientific TMO Stock Holding History

Optimas Capital’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.53M	Buy	+5,040	New	+$2.42M	2.61%	10
2025 Q3	–	Sell	-7,400	Closed	-$3M	–	39
2025 Q2	$3M	Buy	+7,400	New	+$3.09M	3.16%	12
2024 Q1	–	Sell	-5,386	Closed	-$2.86M	–	52
2023 Q4	$2.86M	Buy	+5,386	New	+$2.61M	2.7%	13
2023 Q1	–	Sell	-11,964	Closed	-$6.59M	–	46
2022 Q4	$6.59M	Buy	11,964 +1,185	+11%	+$628K	6.45%	5
2022 Q3	$5.47M	Buy	10,779 +979	+10%	+$548K	4.61%	8
2022 Q2	$5.32M	Sell	9,800 -4,679	-32%	-$2.58M	6.53%	4
2022 Q1	$8.55M	Buy	14,479 +9,900	+216%	+$5.69M	8.03%	3
2021 Q4	$3.06M	Buy	+4,579	New	+$2.86M	6.53%	5

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Optimas Capital's TMO Position: Q2 2026 in Review

Optimas Capital opened a new position in Thermo Fisher Scientific (TMO) in Q2 2026: 5,040 shares worth $2.53M. The stake represents 2.61% of the portfolio and ranks #10 among its holdings. This is a return to the name: Optimas Capital previously reported a position in TMO as recently as Q2 2025.

Optimas Capital first reported a position in TMO in Q4 2021 and has held it in 8 quarters since. The position peaked at $8.55M in Q1 2022. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Optimas Capital held 5,040 shares of Thermo Fisher Scientific worth $2.53M as of Q2 2026.
Thermo Fisher Scientific was a new Optimas Capital position in Q2 2026.
Thermo Fisher Scientific made up 2.61% of Optimas Capital's portfolio in Q2 2026, its #10 holding.
Optimas Capital first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 8 quarters since.
Optimas Capital's Thermo Fisher Scientific position peaked at $8.55M in Q1 2022.
2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Optimas Capital's 13F filing for Q2 2026, filed 3 Aug 2026.